Explore our materials

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016

Lost in translation: learning from preclinical data | Gerry Davies

Charles Peloquin

PharmD

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016

Rifampin vs. Rifapentine: a debate over the preferred rifamycin | Charles Peloquin, PharmD

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016

Rifampin vs. Rifapentine: a debate over the preferred rifamycin | Kelly Dooley, MD, PhD

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016

A new model for early clinical development of TB drugs and its application to Q203 and BTZ043 | Norbert Heinrich, MD

Symposium on Key Issues in Liver Transplantation for NASH 2016

What is an acceptable BMI | Lee Kaplan, MD, PhD

Symposium on Key Issues in Liver Transplantation for NASH 2016

Role of Bariatric Surgery - Pre-, During or Post-Transplant | Julie Heimbachx, MD

Symposium on Key Issues in Liver Transplantation for NASH 2016

Optimizing Immunosuppression | Mohammed Siddiqui

Symposium on Key Issues in Liver Transplantation for NASH 2016

Panel Discussion

Dmitry Manuilov

International Workshop on HBV Cure 2021

Update on the Efficacy and Safety of Bulevirtide for Treatment of Chronic HDV - D. Manuilov, MD

Douglas Mayers

International Workshop on HBV Cure 2021

Active Site Polymerase Inhibitor Nucleotides (APSINs) - D. Mayers, MD

Matthew McClure

International Workshop on HBV Cure 2021

STOP Agents - M. McClure, MD

Leigh Felton

BSc, PhD